Cubist Systematic Strategies, LLC Immatics N.V. Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 278,382 shares of IMTX stock, worth $1.22 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
278,382
Previous 35,394
686.52%
Holding current value
$1.22 Million
Previous $403,000
391.07%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IMTX
# of Institutions
93Shares Held
92.5MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$46.4 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA10.4MShares$45.6 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$41.1 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$31.9 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$28.6 Million0.76% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $334M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...